NorthWest Biotherapeutics Inc (NWBO)

[FeMike]

25,000 Annual GBM patients X $200,000 per DCVax-L treatment = $5 billion per year

Then, $5 billion per year X 15 times multiple = $75 billion Market Value

Then, $75 billion Market Value / 1.5 billion outstanding shares = $50 per share (estimated value)

Look you're welcome to have this opinion but I vehemently disagree.

First, we are discussing UK approval value. Not post FDA approval value. So your 25,000 annual GBM patients is not even remotely relevant. Second, even with full 'global' approval 25,000 patients is quite a stretch.

Third, $200,000 per treatment is wildly high. But, that is speculation so I can't tell you you're wrong. Just that I wouldn't use that number in any sort of estimate.

Anyhow, as I said, we are talking about values immediately upon UK approval. I'm not advising anyone to sell at $5 just guessing what the market cap will be when that day comes.